The last decade has seen remarkable innovation and development in the nucleotide sequencing field. Today, a number of powerful high-throughput sequencing technologies are available and are being used to address an increasingly diverse range of biological problems. The quantitative scale and efficiencies of next-generation sequencing platforms are also seeing unprecedented progress and growth in many areas of fundamental research. Also, dramatic reductions in the associated costs and the operational complexities of these techniques are opening up applications in areas that would have been unimaginable just a decade ago. 

Next-Generation Sequencing (NGS) 2015 presents the findings of a new global study of nucleotide sequencing, which profiled the use of these techniques from the end-userís perspective. This study, which evaluated end-users' current sequencing practices and three-year plans, investigated market growth; the competitive positions of global sequencing suppliers; sequencing techniques and applications, polynucleotide types, advantages and disadvantages of techniques, sequencing costs versus genetic code lengths, use of specialist software; disease areas, sample types and sample preparation, sectors, disease biomarkers and other areas. This involved the participation of 309 end-users across 60 countries and profiled current practices, developments, trends and future plans over the next three years, as well as growth and opportunities across key sectors of these markets. Overall, 50% of end-users are from Europe, while 18% are in North America and 18% in Asia.

The study includes:

  • Current and 3-year market estimates provided by 309 experienced end-users
  • Recent Growth in sequencing and estimated growth over the next 3 years (±% change)
  • Sequencing techniques used currently and anticipated in 3 years (±% change)
  • Current sequencing suppliers and anticipated suppliers in 3 years (±% change)
  • Current sequencing applications and anticipated applications in 3 years (±% change)
  • Disease areas relating to sequencing now and in 3 years (±% change)
  • Nucleotide types currently sequenced and anticipated in 3 years (±% change)
  • Software used by sequencers
  • Costs of sequencing per sample and associated nucleotide lengths
  • Numbers of samples sequenced per month
  • Disease biomarkers investigated using sequencing
  • Biomarker disease areas and molecular types
  • Sample preparation methods used in sequencing
  • Kits for sample preparation, and suppliers, in nucleotide sequencing
  • Purpose, fields or sectors
  • Global regions, countries and organisation types

Full details of Next-Generation 2015

Request your free sample